Companies: 49,246 Total Market Cap: 132596284745423.86

Biohit Oyj

HEL-BIOBV
Healthcare Biotechnology
Rank #29960
Market Cap 45.05 M
Volume 6,562
Price 2.97
Change (%) 1.50%
Country or region Finland Finland

Biohit Oyj's latest marketcap:

45.05 M

As of 05/20/2025, Biohit Oyj's market capitalization has reached $45.05 M. According to our data, Biohit Oyj is the 29960th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 45.05 M
Revenue (ttm) 16.11 M
Net Income (ttm) 2.90 M
Shares Out 15.19 M
EPS (ttm) 0.19
Forward PE 17.53
Ex-Dividend Date n/a
Earnings Date 08/06/2025
Market Cap Chart
Data Updated: 05/20/2025

Biohit Oyj's yearly market capitalization.

Biohit Oyj has seen its market value grow from €37.31 M to €39.94 M since 2020, representing a total increase of 7.04% and an annual compound growth rate (CAGR) of 1.56%.
Date Market Cap Change (%)
05/20/2025 €39.94 M 17.5%
12/30/2024 €34.77 M 22.03%
12/29/2023 €28.49 M 20.61%
12/30/2022 €23.62 M -14.44%
12/30/2021 €27.61 M -26.01%
12/30/2020 €37.31 M

Company Profile

About Biohit Oyj

Biohit Oyj is a biotechnology company specializing in the manufacturing and sale of diagnostic products and systems for research institutions, healthcare, and industrial applications worldwide.

Key Product Offerings

  • Diagnostic Tests:
    • GastroPanel Unified – Comprehensive stomach health check.
    • GastroPanel Four-in-One – Advanced stomach test.
    • GastroSoft – Software assisting clinicians in diagnostics.
    • Biohit Active B12 – Measures total vitamin-B12 serum concentration.
    • BIOHIT Total 25OH Vitamin D – Determines vitamin D2 and D3 levels.
    • Biohit Calprotectin – Differentiates between inflammatory bowel disease and irritable bowel syndrome.
  • Quick Tests:
    • GastroPanel Quick Test NT – Detects H. pylori and atrophic gastritis.
    • BIOHIT Celiac Quick Test – Diagnoses celiac disease.
    • Biohit ColonView Quick Test – Detects fecal occult blood.
    • Biohit H. pylori UFT300 & Quick Test – Identifies H. pylori infection.
    • Lactose Intolerance Quick Test – Supports lactose intolerance diagnosis.
  • Acetaldehyde-Binding Products:
    • Acetium Capsules – For low-acid stomach and chronic H. pylori infection.
    • Acetium Lozenges – Aids in smoking cessation.
  • Monoclonal Antibodies: Used in cellular pathology, neurobiology, oncology, and gastric biomarker research.
  • Biohit Faex: Stool sample collection and processing solution.

Company Background

Founded in 1988, Biohit Oyj is headquartered in Helsinki, Finland, and continues to innovate in biotechnology and diagnostic solutions.

Frequently Asked Questions

As of 05/20/2025, Biohit Oyj (including the parent company, if applicable) has an estimated market capitalization of $45.05 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Biohit Oyj global market capitalization ranking is approximately 29960 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Finland
Founded 1988
IPO Date n/a
Employees 46
CEO Jussi Hahtela
Sector Healthcare
Industry Biotechnology
Address Laippatie 1
Helsinki, 00880
Finland
Website https://www.biohithealthcare.com